Alzheimer's Disease Trial, Recruiting NCT05296980 Sponsor: University of Coimbra Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05296980
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged 60 or older
  • People who have a CAIDE dementia risk score higher than 8 (this is a score based on factors like age, lifestyle, and health history that estimates dementia risk — the trial site can confirm this score)
  • People who do not have significant memory or thinking problems, as measured by a specific cognitive test called the Addenbrooke's Cognitive Examination-Revised
  • People who do not have physical disabilities that would prevent them from taking part in the study activities
  • People who are willing and able to complete all study activities over a 12-week period

Who may not be able to join:

  • People who have already been diagnosed with mild cognitive impairment or dementia
  • People who have a history of a neurological event (such as a stroke or brain injury) that may have affected their current thinking or memory
  • People who have a severe psychiatric disorder (note: mild depression or anxiety symptoms do not appear to prevent participation — confirm with trial site)
  • People who are unable to travel to the location where sessions are held (confirm with trial site, as online participation options may exist for some groups)
  • People who are unable to read or write

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +351962779695

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Coimbra
Registry
ClinicalTrials.gov
Start date
1 April 2022
Est. completion
2 May 2024

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Cognitive status composite; Functionality status; Blood biomarkers of neural damage; Cognitive status composite; Functionality status; Cognitive status composite; Functionality status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov